|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||240.56 - 249.39|
|52 Week Range||188.32 - 324.99|
|Beta (3Y Monthly)||1.30|
|PE Ratio (TTM)||26.03|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
WellCare Health (WCG) unit introduces a unique mobile app, Atlas Compass, to assist PBM members to manage their pharmacy health information.
Riding high on solid segmental performances, Universal Health (UHS) promises to reap great benefits for investors. However, its debt load bothers.
HCA Healthcare (HCA) to purchase the majority interest in Galen College of Nursing for boosting access to nursing education.
Riding high on robust Medicare business and strategic buyouts, Humana (HUM) looks promising to reap benefits for investors.
A year into the role, Rachelle Sico is leading a team that manages hundreds in annual insurance regulatory filings and insurance licenses for more than 200 affiliates throughout the country.
Anat Hakim has been with the company for close to three years, though she’s practiced law for 26 years.
A U.S. judge who has been asked to sign off on a government agreement that allowed CVS Health Corp to buy health insurer Aetna ordered a hearing for April 5. Judge Richard Leon of the U.S. District Court for the District of Columbia issued the order on Thursday, saying that he wanted the hearing to discuss which witnesses, if any, should testify before he decides whether to approve the government's deal with the companies. The Justice Department approved the merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc. That deal has also closed.
Though most of the stocks in the S&P 500 ETF have delivered astounding returns during the decade, a few were the real stars, skyrocketing more than 2000%.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
DEEP DIVE Stock prices have soared so far this year, following a dismal fourth quarter. But the best sector of 2018 — health care — has shown only a modest gain in 2019. With an aging population and so much government money pouring into the industry, it is only reasonable to try to ride the long-term wave.
Riding high on a solid inorganic growth profile and divestitures, Tenet Healthcare (THC) holds ample chances of reaping benefits for investors.
WellCare (WCG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
A unit of Ensign Group's (ENSG) subsidiary buys the assets of All County Home Care and Hospice to boost its health and hospice portfolio.
Banking on a strong revenue stream and strategic efforts, Anthem (ANTM) holds great advantage to reap profitable returns for investors.
Ensign Group (ENSG) purchases Downey Care Center to penetrate into Southern Californian region and enrich its portfolio.
WellCare Health Plans, Inc. (NYSE:WCG) shareholders have seen the share price descend 12% over the month. But that doesn't change the fact that the returns over the last five yearsRead More...
The intraday U-turn in the SPDR Health Care Select Sector ETF has produced a "bearish engulfing" reversal chart pattern, which many technicians would say warns that the 2-month uptrend in the sector has ended. The ETF (XLV) opened $93.28, above the Friday's close of $92.95, then rose to a 3-month high of $93.45 in intraday trade before reversing course to close at $91.69, or below Friday's open of $92.22. Candlestick-chart followers believe this pattern suggests that after bears took the bulls' best shot, they launched a successful counterattack that have left bulls retreating. The XLV's decliners Monday were led by shares of managed care companies WellCare Health Plans Inc. , Anthem Inc. and Humana Inc. . Among some downside levels to watch are the 200-day moving average, which currently extends to $89.23, and the 61.8% Fibonacci retracement of the rally off the Dec. 24 closing low to Friday's high, which comes in at $85.38. The XLV has gained 6.0% year to date while the S&P 500 has run up 13.0%.
Shares of managed care and provider companies slumped for a second-straight session Thursday, in the wake of the introduction of the Medicare-for-All Act to Congress on Wednesday. The bill, introduced by Reps. Pramila Jayapal of Washington, Debbie Dingell of Michigan and others looks for a quick 2-year transition out of employer-sponsored coverage into single-payor Medicare run by the government. Analyst Gary Taylor at J.P. Morgan said he doesn't expect a quick snap-back rally in the managed care and provider stocks this week, but doesn't believe they could rally off lows by summer. He then expects that rally to fade into the second half of the year, as Democratic Presidential debates begin in the fall. Shares of UnitedHealth Group Inc. lost 3% to pace the Dow Jones Industrial Average's decliners, after losing 4.9% on Wednesday; Cigna Corp. sank 3.4%, after falling 4.0% on Wednesday; Humana Inc. shed 1.0% after dropping 4.8% the day before; WellCare Health Plans Inc. slid 3.3% after giving up 3.9% Wednesday; and Anthem Inc. declined 1.8% after losing 3.6% on Wednesday. In comparison, the Dow slipped 0.2% after easing 0.3% the day before.
Banking on solid growth strategies and increasing revenues, Ensign Group (ENSG) has great potential to offer benefits to investors.
Investing.com - Mylan slumped Wednesday, sending healthcare stocks into the red after the pharma giant delivered earnings and guidance that fell short of estimates.
The retirements are effective this spring, when the two will not seek re-election at the company’s annual meeting of shareholders.
Other featured articles offer looks at a health care stock hurt by overblown worries and a bargain among sin stocks. The Cold War in Tech" by Reshma Kapadia, suggests that the battle for tech supremacy between the United States and China shows little sign of abating. In "WellCare Poised to Ride Surging Medicare and Medicaid Spending," Lawrence C. Strauss shows how WellCare Health Plans, Inc. (NYSE: WCG) has been hurt by overblown worries about its swift growth, earnings outlook and more.